Patel Nisarg, Nooli Nishank, Sundt Linda
Department of Anesthesiology, Thomas Jefferson University Hospital, Philadelphia, PA, USA.
J Cardiol Cases. 2020 Feb 14;21(5):186-188. doi: 10.1016/j.jccase.2020.01.007. eCollection 2020 May.
Giant cell myocarditis is a rare and frequently fatal disease that requires extensive cardiac care. Given the rarity of this condition no specific management recommendations exist. We describe a patient who presented with congestive heart failure that required a left ventricular assist device and a temporary right ventricular assist device along with immunosuppressive therapy. This case also brings to attention how undocumented immigration status can limit transplantation opportunities in the USA. < Giant cell myocarditis is a rare and frequently fatal cardiac disease that, until the 1980s, was only diagnosed during autopsy. It is commonly seen in young and middle-aged, otherwise healthy, individuals with median transplant-free survival of 5.5 months from diagnosis. Current treatments with immunosuppressant medications do not seem to be significantly effective. Most patients require transplant or ventricular assist device for survival.>.
巨细胞性心肌炎是一种罕见且常致命的疾病,需要全面的心脏护理。鉴于这种疾病的罕见性,目前尚无具体的管理建议。我们描述了一名出现充血性心力衰竭的患者,该患者需要左心室辅助装置和临时右心室辅助装置以及免疫抑制治疗。该病例还引起了人们对无记录移民身份如何限制美国移植机会的关注。<巨细胞性心肌炎是一种罕见且常致命的心脏病,直到20世纪80年代,它仅在尸检时被诊断出来。它常见于年轻和中年、其他方面健康的个体,从诊断起无移植生存的中位时间为5.5个月。目前使用免疫抑制药物的治疗似乎效果并不显著。大多数患者需要移植或心室辅助装置才能生存。>